Velomedix snags $3.5M to treat hypothermia
Velomedix, a biotech company that makes treatments for hypothermia, has raised $3.5 million in a first round of preferred stock, according to a filing with the SEC. Based in Menlo Park, Calif., it is backed by Life Science Angels, Longitude Capital and Wavepoint Ventures.
Next Story: Kyte brings high-end mobile video publishing to Android, Nokia
Previous Story: Calling great writers: VentureBeat is hiring!
About the Author, Camille Ricketts
Camille was the lead writer for GreenBeat until August 2010. To reach VentureBeat's current writers, email tips@venturebeat.com.
